Fundraising Fox

Q'Apel Medical

Fremont, US · Delaware corporation · 4 known investors

Find your way into Q'Apel Medical

Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.

HardwareHealthtechMedical Devices

Founders & leadership

RKR. King Nelson
R. King NelsoninExecutive Chairman , Board of DirectorsExecutive Officer, Director at Uptake Medical
CM
Christopher MartinNamed on SEC filing
JA
J. Avi RoopNamed on SEC filing
SH
Scot HuennekensNamed on SEC filing

Board

CM
Carter McNabbBoard director

Investors · 4

RC CapitalreportedCincinnati
Research Corporation TechnologiesreportedTucson
River Cities CapitalreportedCincinnati
Soleus CapitalreportedGreenwich

Reported raises · per SEC filings

Form D private placements

$68.9M disclosed across 3 rounds · 2021–2024

▶$17.1MraisedMay 2024 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • R. King NelsonExecutive Officer, Director
  • Scott HuennekensDirector
  • Carter McNabbDirector
  • Lennox KetnerDirector
  • Christopher MartinDirector
Offering amount
$42.1M
Amount sold
$17.1M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.9MraisedMay 2022 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Scot HuennekensDirector
  • J. Avi RoopDirector
  • Carter McNabbDirector
  • R. King NelsonExecutive Officer, Director
  • Christopher MartinDirector
Offering amount
$33M
Amount sold
$29.9M
First sale
Mar 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.9MraisedFeb 2021 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • R. King NelsonExecutive Officer, Director
  • Christopher MartinDirector
  • J. Avi RoopDirector
  • Carter McNabbDirector
  • Scot HuennekensDirector
Offering amount
$22M
Amount sold
$21.9M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Cqmedical16 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.

Companies competing with Q'Apel Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Q'Apel Medical Raises $22 Million to Grow Highly Innovative Neurovascular Access Platform & Scott Huennekens Joins Board of Directors | RC Capitalrccf.com · Feb 2021Q'Apel Medical Raises $22M in Fundingfinsmes.com · Feb 2021Q'Apel Medical Raises $22 Million: Funds Will Help Grow A Highly Innovative Neurovascular Access Platform - Medical Device News Magazineinfomeddnews.com · Feb 2021

Frequently asked questions

What does Q'Apel Medical do?
Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.
Who are Q'Apel Medical's investors?
Q'Apel Medical's investors include RC Capital, Research Corporation Technologies, River Cities Capital, Soleus Capital.
How much funding has Q'Apel Medical raised?
Q'Apel Medical has disclosed $68.9M raised across 3 rounds.
Where is Q'Apel Medical headquartered?
Q'Apel Medical is headquartered in Fremont, US.